跳至主要内容
临床试验/NCT02839408
NCT02839408Unknown2 期

Efficacy of Oral Probiotic and Antibiotic Administration in Clinical, Immunological and Microbiological Parameters of Patients With Chronic Periodontitis Treated With Non Surgical Periodontal Treatment

University of Chile1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
54
试验地点
1
主要终点
Differences of at least 1mm between groups for clinical attachment level changes

研究概览

简要总结

The aim of this randomized placebo- controlled clinical trial is to evaluate the effects of Lactobacillus rhamnosus SP1- containing probiotic tablets and azithromycin tablets as an adjunct to scaling and root planning (SRP).

Material and methods: Fifty-four chronic periodontitis patients will be recruited and monitored clinically, immunologically and microbiologically at baseline, 3, 6, 9 and 12 months after therapy. All patients will receive scaling and root planning and randomly will be assigned over an probiotic experimental (SRP + probiotic, n=18), antibiotic experimental (SRP + Azithromycin, n=18) or control (SRP + placebo, n=18) group. Probiotic will be used once per day during 3 months. Antibiotic will be used once per day during 5 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 14 natural teeth, excluding third molars
  • 10 posterior teeth
  • 35 years old
  • 5 teeth with periodontal sites with probing depths ≥5mm, clinical attachment loss ≥3mm Bleeding on probing ≥20% of sites Extensive bone loss determined radiographically

排除标准

  • Periodontal treatment before the time of examination
  • Systemic illness
  • Pregnancy Anticoagulant, antibiotics and non- steroid anti- inflammatory therapy in the 6-month period before the study

研究组 & 干预措施

Periodontal treatment, talc powder tab

Placebo Comparator

Periodontal treatment (scaling and root planning) and one tablet containing talc powder per day during 3 months

干预措施: Talc powder (Other)

Periodontal treatment, talc powder tab

Placebo Comparator

Periodontal treatment (scaling and root planning) and one tablet containing talc powder per day during 3 months

干预措施: Periodontal treatment Scaling and root planning (Procedure)

Periodontal treatment, Probitic

Experimental

Periodontal treatment (scaling and root planning) and one sachet containing Lactobacillus rhamnosus SP1 per day during 3 months.

干预措施: Lactobacillus rhamnosus SP1 (Dietary Supplement)

Periodontal treatment, Probitic

Experimental

Periodontal treatment (scaling and root planning) and one sachet containing Lactobacillus rhamnosus SP1 per day during 3 months.

干预措施: Periodontal treatment Scaling and root planning (Procedure)

Periodontal treatment, Antibiotic

Experimental

Periodontal treatment (scaling and root planning) and one tablet containing 500mg Azithromycin

干预措施: Azithromycin (Drug)

Periodontal treatment, Antibiotic

Experimental

Periodontal treatment (scaling and root planning) and one tablet containing 500mg Azithromycin

干预措施: Periodontal treatment Scaling and root planning (Procedure)

结局指标

主要结局

Differences of at least 1mm between groups for clinical attachment level changes

时间窗: baseline, 3, 6, 9 and 12 month

次要结局

  • Differences between groups for probing depth changes(baseline, 3, 6, 9 and 12 month)
  • Differences between groups for bleeding on probing changes(baseline, 3, 6, 9 and 12 month)
  • Differences between groups for levels of Interleukin (IL)-17, IL-8, beta-defensing 3 changes in gingival crevicular fluid(baseline, 3, 6, 9 and 12 month)
  • Differences between groups for levels of periodontal pathogens changes(baseline, 3, 6, 9 and 12 month)
  • Differences between groups for plaque index changes(baseline, 3, 6, 9 and 12 month)

研究者

发起方
University of Chile
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jorge Gamonal

Prof

University of Chile

研究点 (1)

Loading locations...

相似试验